GlassScriptPhysician profile
Evelyn Artz
NPI 1508929373
$1,258.06
in general payments reported to CMS, 2019-2025
21 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $18.04 · 2021: $83.06 · 2022: $171 · 2023: $269 · 2024: $390 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $218.67 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $129.54 | 2023-2024 | |
| Dexcom, INC. | $121.37 | 2019-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $102.74 | 2023-2024 | Minimed 780g |
| Pfizer INC. | $89.56 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $85.51 | 2022-2024 | Triptodur, Triptodur |
| Medtronic Minimed, INC. | $54.12 | 2019-2020 | |
| Insulet Corporation | $47.19 | 2019-2024 | Omnipod |
| Jazz Pharmaceuticals INC. | $44.62 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $44.39 | 2021-2022 | |
| Ascendis Pharma Endocrinology INC | $43.99 | 2023-2024 | |
| Eton Pharmaceuticals, INC. | $41.96 | 2023-2025 | Alkindi, Khindivi, Increlex |
| Abbvie INC. | $41.47 | 2021-2023 | Lupron Depot |
| Sequel Med Tech, LLC | $38.97 | 2025 | Twiist |
| Kyowa Kirin, INC. | $37.49 | 2023-2025 | Crysvita |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immedica Pharma US, INC. | $33.62 | 2022 | |
| Xeris Pharmaceuticals, INC. | $23.61 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.71 | 2019 | |
| Biomarin Pharmaceutical INC. | $16.08 | 2022 | |
| Ptc Therapeutics, INC. | $14.20 | 2021 | |
| Alexion Pharmaceuticals, INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evelyn Artz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.